We are live on !
Find out more
Ulys LLC Portfolio holdings
AUM
$25.4M
Turnover
0%
1-Year Est. Return
201.03%
This Fund
S&P 500
This Quarter Est. Return
-23.46%
1 Year Est. Return
+201.03%
3 Year Est. Return
-31.51%
5 Year Est. Return
-50.88%
10 Year Est. Return
–
AUM
$59.8M
AUM Growth
-$18.3M
(-23%)
Cap. Flow
$0
Cap. Flow % of AUM
Cap. Flow %
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
3.5
years
Top 10 Avg Time Held
3.5
years
Top 20 Avg Time Held
3.5
years
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Lexicon Pharmaceuticals
LXRX
$659M
| $59.8M | 100% |
4,321,214
| – | – |
2013 Q2
14 quarters
|
|
Similar funds
AGEC
Ulys LLC's Q4 2016 Portfolio in Review
As of Q4 2016, Ulys LLC held 1 position worth $59.8M, down 23% from $78.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q4 2016: portfolio turnover was 0%. Ulys LLC opened no new positions and made no exits, leaving the 1-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Ulys LLC's ten largest holdings make up 100% of its $59.8M portfolio in Q4 2016.
- Ulys LLC opened 0 new positions and closed 0 in Q4 2016.
- Ulys LLC's portfolio value fell 23% quarter-over-quarter to $59.8M.
Based on Ulys LLC's 13F filing for Q4 2016, filed 14 Feb 2017.